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Abstract
Background: The genetic diversity and the clinical relevance of the drug-resistant Klebsiella pneumoniae isolates from
hospital settings are largely unknown. We thus conducted this prospective study to analyze the molecular epidemiology of
K. pneumoniae isolates from patients being treated in the 306 Hospital in Beijing, China for the period of November 1, 2010–
October 31, 2011.
Methodology/Principal Findings: Antibiotic susceptibility testing, PCR amplification and sequencing of the drug resistance-
associated genes, and multilocus sequence typing (MLST) were conducted. A total of 163 isolates were analyzed. The
percentage of MDR, XDR and PDR isolates were 63.8% (104), 20.9 (34), and 1.8% (3), respectively. MLST results showed that
60 sequence types (STs) were identified, which were further separated by eBURST into 13 clonal complexes and 18
singletons. The most dominant ST was ST15 (10.4%). Seven new alleles and 24 new STs were first identified in this study.
Multiple logistic regression analysis revealed that certain clinical characteristics were associated with those prevalent STs
such as: from ICU, from medical ward, from community acquired infection, from patients without heart disease, from
patients with treatment success, susceptible to extended spectrum cephalosporin, susceptible to cephamycins, susceptible
to fluoroquinolones, and with MDR.
Conclusions/Significance: Our data indicate that certain drug-resistant K. pneumoniae clones are highly prevalent and are
associated with certain clinical characteristics in hospital settings. Our study provides evidence demonstrating that intensive
nosocomial infection control measures are urgently needed.
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Introduction
Klebsiella pneumoniae is an important bacterial pathogen associ-
ated with community acquired (CA) and hospital acquired (HA)
infections and has the potential to cause severe morbidity and
mortality, particularly in immunocompromised patients [1–3].
Infections caused by drug-resistant K. pneumoniae isolates, especially
those produce extended-spectrum beta-lactamases (ESBLs) and
which are multidrug-resistant (MDR), extensively drug-resistant
(XDR) or pandrug-resistant (PDR), are more difficult and
expensive to treat with worse treatment outcome [4–8]. More
recently, carbapenem-resistant K. pneumoniae have been reported
worldwide as a consequence of acquisition of carbapenemase
genes, and a large variety of carbapenemases have been identified
in K. pneumoniae [9–14].
Rapid and discriminative genotyping methods are useful for
determining the clonality of the isolates in nosocomial or
household outbreaks [15,16]. Multilocus sequencing typing
(MLST) is a nucleotide sequence-based approach for character-
izing bacterial isolates (http://www.mlst.net/), with the advantage
over traditional pulsed-field gel electrophoresis (PFGE) of ease of
manipulation and convenient comparison [17,18]. In our previous
study, we observed alarmingly high rates of MDR, XDR and PDR
strains among K. pneumoniae isolates from a tertiary care hospital in
Beijing, China [19]. In addition, data from that study indicate that
many of the drug resistance genes were transmissible [19]. Since
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the genetic diversity, transmission patterns and the clinical
relevance of the drug-resistant K. pneumoniae isolates from hospital
settings are largely unknown, we thus further conducted this
MLST genotyping analysis for K. pneumoniae isolates from the 306
Hospital, a tertiary care hospital in Beijing, China for the period of
November 1, 2010–October 31, 2011 with an aim to assess the
molecular epidemiology as well as clinical characteristics associ-
ated with prevalent K. pneumoniae clones.
Methods
Ethics statement
All of the investigation protocols in this study were approved by
the institutional ethics committee of the 306 Hospital, Beijing,
China. Written informed consent for K. pneumoniae isolates to be
collected as well as for their information to be stored in the hospital
database for research purposes was provided by participants.
Written informed consent was obtained from the next of kin,
caretakers, or guardians on the behalf of the minors/children
participants involved in this study. Permission for using the
information in the medical records of the patients for research
purposes was obtained from the 306 Hospital. The Institute ethics
committee of the 306 Hospital reviewed that relevant ethical issues
in this study were considered.
Study population, bacterial isolate identification, and
drug susceptibility testing
The 306 Hospital in Beijing, China is a tertiary care hospital,
with 1,100 beds and approximately 25,000 hospital admissions per
year. Consecutive non-repetitive K. pneumoniae isolates were
collected from patients being treated in the 306 Hospital for the
period of November 1, 2010–October 31, 2011. Isolates with
ambiguous sequence data for one or more alleles were excluded
from the analysis. All isolates were cultured in Luria-Bertani (LB)
medium. A total of 175 isolates were confirmed as K. pneumoniae by
16S rDNA sequencing. Drug susceptibility testing (DST) for the K.
pneumoniae isolates was performed using the bioMe´rieux VITEK2
system following manufacturer’s instructions. The following 18
drugs were tested: ampicillin (AMP), piperacillin/tazobactam
(TZP), ampicillin/sulbactam (SAM), cefazolin (CFZ), ceftriaxone
(CRO), ceftazidime (CAZ), cefepime (FEP), cefotetan (CTT),
ertapenem (ETP), imipenem (IM), aztreonam (ATM), ciproflox-
acin (CIP), levofloxacin (LVX), gentamicin (GM), tobramycin
(TOB), amikacin (AMK), trimethoprim-sulfamethoxazole (SXT),
and nitrofurantoin (FD). The ESBLs were detected by the
bioMe´rieux VITEK-2 AST-GN13 test. In some cases, the ESBL
positivity was further confirmed by the double disk diffusion
method according to standard protocols by the Clinical Labora-
tory Standard Institute (CLSI) [20]. Escherichia coli strains ATCC
25922 and ATCC 35218, Klebsiella pneumoniae strain ATCC
700603 and Pseudomonas aeruginosa strain ATCC 27853 were used
as quality control strains for the DST. Clinical records of patients
from whom the K. pneumoniae isolates were obtained were reviewed
retrospectively.
PCR amplification and sequencing for drug resistance
genes
Drug resistance-associated genes were detected by PCR and
sequencing using 37 pairs of primers as described previously [19].
The drug resistance-associated genes examined include: blaCTX-M-1,
blaCTX-M-2, blaCTX-M-3, blaCTX-M-8, blaCTX-M-9, blaCTX-M-10,
blaCTX-M-14, blaCTX-M-25, blaSHV-group, blaTEM, blaKPC, blaNDM,
blaIMP, blaVIM, blaOXA-48, blaCMY, blaDHA, blaFOX, dhfr, qnrA, qnrB,
qnrC, qnrD, qnrS, aac(69)-Ib-cr, qepA, gyrA, parC, aacA4, aacC1, aacC2,
aadA1, aadB, aphA6, armA, rmtB, and Integron I. DNA sequences were
annotated using the BLAST program at http://www.ncbi.nlm.nih.
gov.
Genotyping of K. pneumoniae isolates by MLST analysis
Genotyping was determined by MLST analysis. MLST with
seven genes (gapA, infB, mdh, pgi, phoE, rpoB and tonB) was
performed on isolates according to the protocol described on the
K. pneumoniae MLST website (www.pasteur.fr/mlst) [18]. Alleles
and sequence types (STs) were assigned by using the MLST
database (www.pasteur.fr/mlst/Kpneumoniae.html). Alleles and
STs that had not been previously described were submitted to the
curator of the database and were assigned new designations.
Assignment to clonal complexes
The program eBURST v 3.0 was used to identify the different
clonal complexes [21]. Clonal complexes were defined as groups
of two or more independent isolates that shared identical alleles at
six or more loci; each complex was named after the putative
founder ST. Data from additional 1,380 isolates of K. pneumoniae
were obtained from the MLST isolate database deposited at the
Pasteur Institute (http://www.pasteur.fr/cgi-bin/genopole/PF8/
mlstdbnet.pl?file = klebs_isolates.xml) [18].
Sequence analysis
The proportions of nucleotide alterations that led to a change in
the amino acid sequence (non-synonymous substitution, dn) and
the proportions of nucleotide alterations that did not lead to a
change in the amino acid sequence (synonymous substitution, ds)
were calculated with START2 [22]. Phylogenetic analysis was
performed using ClonalFrame algorithm with the software
package ClonalFrame version 1.1 [23], using 50,000 burn-in
cycles and 100,000 further iterations. Maximum likelihood tree
was constructed using PhyML 3.0 under a GTR+I+G model
based on the alignment of concatenated sequence from the seven
MLST gene loci with 1000 bootstrap replicates [24].
Measurement of clonality
The standardized index of association (IA
S) for the seven loci was
calculated using START2 software and 1,000 iterations [22]. IA
S
was also estimated using 764 unique STs including the new STs in
this study and existing STs in the entire MLST isolate database as
a whole.
Definitions
Every patient was counted only once during his hospital stay
regardless of the number of positive cultures. Each case was
differentiated between CA infection and HA infection based on a
temporal definition. A CA case was defined as a case with known
carriage of K. pneumoniae on admission or with the first culture
positive for these bacteria within 48 h of admission [6,25]. A HA
case was defined by the first culture positive obtained more than
48 h after admission. MDR was defined as acquired non-
susceptibility to at least one agent in three or more antimicrobial
categories, XDR was defined as non-susceptibility to at least one
agent in all but two or fewer antimicrobial categories (i.e. bacterial
isolates remain susceptible to only one or two categories) and PDR
was defined as non-susceptibility to all agents in all antimicrobial
categories [7].
Statistical analyses
Data were entered and analysed using the statistical package
SPSS for windows (version 15). Two people were independently
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cross-checked each entry to ensure the quality of data entered into
the computer. For categorical data, different groups were
compared using the Chi-square test. Univariate and multivariate
analyses were used to determine the factors associated with
prevalent K. pnuemoniae clones. The factors examined were shown
in Table S5. All Potentially associated factors were included in a
logistic regression model for multivariate analysis, and they were
eliminated using a backward stepwise selection method using a P
value threshold of 0.1 for the variables to be remained in the
model. Mantel-Haenszel odds ratios (ORs), 95% confidence
intervals (CIs) and corresponding P values were reported. P value
of ,0.05 was considered to be statistically significant.
Results
Demographic and clinical characteristics of the patients
From November 1, 2010 to October 31, 2011, a total of 175
non-repetitive hospitalized patients who had K. pneumoniae isolates
available were subjected to DST at the 306 Hospital. Twelve
(6.9%) patients were excluded from the study as a result of low-
quality sequencing results for one or more of the 7 house-keeping
genes of their isolates. Among the remaining 163 patients, 126
(77.3%) were HA cases and 37 (22.7%) were CA cases. Eighty
(49.1%) isolates were ESBL positive and 83 (50.9%) isolates were
ESBL negative. The proportion of the male and female patients
were 73.6% (120/163) and 26.4% (43/163), respectively. Fifty-
four (33.1%) of the patients were Beijing residents and the rest
were from other provinces of China (non-Beijing residents). The
median (6SD) age of the patients was 74.50619.16 years (range
1–98 years). The majority of the patients were from medical ward
(75/163, 46.0%) and intensive care unit (ICU) (49/163, 30.1%).
The main source of the specimens was sputum (121/163, 74.2%).
The proportion of MDR, XDR, PDR, and other types of K.
pneumoniae isolates were 63.8% (104/163), 20.9% (34/163), 1.8%
(3/163) and 13.5% (22/163) respectively. Notably, the rates of
resistance to most drugs were much higher among ESBL positive
isolates than ESBL negative isolates. The epidemiology of CA and
HA cases based on the admission date is shown in Fig. 1. More
detailed information on relevant demographic and clinical
characteristics of the study population is summarized in Table 1.
MLST analysis of the K. pneumoniae isolates and
identification of clonal complexes
MLST was conducted to determine the extent of genotypic
diversity among the K. pneumoniae isolates. Sixty different STs were
identified by MLST. Thirty-seven of the STs contained single
isolates, while 23 STs included between 2 and 17 isolates. 24 (40%)
of the 60 STs had not been previously identified, 16 of these
differed from recognized STs at only a single locus, 5 of these
(ST877, ST882, ST883, ST890 and ST891) differed from
recognized STs at two loci, and 3 of these (ST886, ST893 and
ST894) differed from recognized STs at three loci (Table S1). The
60 STs generated in this data set were separated by eBURST into
13 clonal complexes and 18 singletons with the default stringent
definition of the groups by sharing alleles at 6 of 7 loci (Fig. 2 and
3, Table 2, and Table S1). The most dominant ST was ST15
(10.4%, 17/163), followed by ST562 (8.6%, 14/163), ST23 (7.4%,
12/163), ST716 (6.1%, 10/163), ST11 (5.5%, 9/163), ST147
(4.9%, 8/163). Those 6 STs accounted for 42.9% (70/163) of the
total isolates, and those 70 isolates were thus designated prevalent
clones in this study. Two of the three PDR isolates in this study
belonged to ST15.
Measurement of clonality and selection pressure
Analysis of the data set of 163 isolates from patients yielded an
IA
S value of 0.1251. This was decreased to 0.0841 when only one
representative of each sequence type was included. Significant
linkage disequilibrium was detected in both analyses. It remained
significant when only one representative isolate for each ST in the
Figure 1. Epidemiology of hospitalized patients that were colonized or infected with K. pneumoniae isolates in the 306 Hospital
during November 1, 2010–October 31, 2011. Note: HA: hospital acquired; CA: community acquired.
doi:10.1371/journal.pone.0057091.g001
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Table 1. Demographic and clinical characteristics of the patients.
Characteristics Total n =163 (%)
ESBL positive cases
n=80 (%)
ESBL negative cases
n=83 (%) P value
Gender 0.166
Male 120 (73.6) 55 (68.8) 65 (78.3)
Female 43 (26.4) 25 (31.3) 18 (21.7)
Age group, years
,15 6 (3.7) 3 (3.8) 3 (3.6) 0.963
15–60 31 (19.0) 14 (17.5) 17 (20.5) 0.628
.60 126 (77.3) 63 (78.8) 63 (75.9) 0.665
Residence situation 0.406
Beijing resident 54 (33.1) 29 (36.3) 25 (30.1)
Non-Beijing resident 109 (66.9) 51 (63.8) 58 (69.9)
Hospital location
Emergency room 8 (4.9) 3 (3.8) 5 (6.0) 0.502
Intensive care unit 49 (30.1) 27 (33.8) 22 (26.5) 0.313
Medical ward 75 (46.0) 37 (46.3) 38 (45.8) 0.952
Surgical ward 31 (19.0) 13 (16.3) 18 (21.7) 0.377
Sources of specimens
Sputum 121 (74.2) 60 (75.0) 61 (73.5) 0.826
Urine 12 (7.4) 9 (11.3) 3 (3.6) 0.062
Throat or nose swabs 13 (8.0) 3 (3.8) 10 (12.0) 0.051
Blood 8 (4.9) 5 (6.3) 3 (3.6) 0.436
Others 9 (5.5) 3 (3.8) 6 (7.2) 0.331
Underlying diseases
Pneumonia 14 (8.6) 6 (7.5) 8 (9.6) 0.610
Diabetes mellitus 40 (24.5) 19 (23.8) 21 (25.3) 0.786
Chronic bronchitis 11 (6.7) 6 (7.5) 5 (6.0) 0.721
Chronic obstructive pulmonary disease 14 (8.6) 7 (8.8) 7 (8.4) 0.959
Abnormal liver function 36 (22.1) 13 (16.3) 23 (27.7) 0.070
Renal dysfunction 35 (21.5) 21 (26.3) 14 (16.9) 0.152
Hypertension 84 (51.5) 39 (48.8) 45 (54.2) 0.427
Heart disease 55 (33.7) 30 (37.5) 25 (30.1) 0.337
Cerebral infarction 41 (25.2) 22 (27.5) 19 (22.9) 0.520
Pulmonary infection 81 (49.7) 42 (52.5) 39 (47.0) 0.513
Urinary tract infection 11 (6.7) 4 (5.0) 7 (8.4) 0.383
Infection acquired model 0.665
Community acquired 37 (22.7) 17 (21.3) 20 (24.1)
Hospital acquired 126 (77.3) 63 (78.8) 63 (75.9)
Drug resistance profiles
Penicillins 162 (99.4) 80 (100.0) 82 (98.8) 0.325
1st and 2nd generation cephalosporins 86 (52.8) 78 (97.5) 8 (9.6) ,0.001
3rd and 4th generation cephalosporins 86 (52.8) 77 (96.3) 9 (10.8) ,0.001
Cephamycins 108 (66.3) 37 (46.3) 71 (85.5) ,0.001
Carbapenems 12 (7.4) 8 (10.0) 4 (4.8) 0.205
Monobactams 83 (50.9) 77 (96.3) 6 (7.2) ,0.001
Fluoroquinolones 72 (44.2) 53 (66.3) 19 (22.9) ,0.001
Aminoglycosides 90 (55.2) 71 (88.8) 19 (22.9) ,0.001
Folate pathway inhibitors 94 (57.7) 76 (95.0) 18 (21.7) ,0.001
Nitrofurantoin 145 (89.0) 77 (96.3) 68 (81.9) 0.004
Drug resistance types
MDR-KP 104 (63.8) 49 (61.3) 55 (66.3) 0.505
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entire isolate database were considered (IA
S = 0.1133), thus the
observed linkage disequilibrium is not due to sampling bias. The
values of IA
S in these analyses were low suggesting the weakly
clonal population. The dn/ds ratios for all loci were significantly
less than 1 (Table S2), indicating there was no strong positive
selective pressure on the genes.
Phylogenetic analysis
The maximum likelihood tree show a phylogenetically distinct
cluster of related STs (ST877, ST886, ST894, ST856 and ST526)
is formed with strong bootstrap support. Four of them (ST877,
ST886, ST894 and ST856) are new STs in this study, and 2 of
these (ST886 and ST894) differed from recognized STs at three
loci (Fig. 4). The drug resistance profiles and epidemiological
information of those clones belonging to phylogenetically distinct
cluster of related STs are shown in Table S3.
Drug resistance profiles of K. pneumoniae isolates
grouped by CCs and STs
The detailed information on drug resistance profiles of K.
pneumoniae isolates grouped by CCs is shown in Table 3. All CCs
showed high proportion of resistance to penicillin. We did not
observe significant differences between ESBL blaCTX-M and
blaTEM/SHV groups (Table 2 and Table 3). We also compared
the drug resistance profiles, the corresponding drug resistance-
associated genes, as well as the clinical characteristics of the
prevalent K. pneumoniae clones (Table S4). We observed that some
isolates with the same STs were from patients who were
hospitalized in the same period and who shared the same wards,
especially in the first ward of the department of respiration, neuro-
intensive care unit (NICU), and ICU. In addition, we detected a
large variety of ESBL genes (such as blaSHV and blaCTX-M, and
blaTEM), as well as genes associated with resistance to fluoroquin-
olones (such as qnrA, qnrB, qnrC, qnrD, qnrS, aac(69)-Ib-cr, and qepA)
and aminoglycosides (such as aacC2, addA1, and aacA4) in the
Table 1. Cont.
Characteristics Total n =163 (%)
ESBL positive cases
n=80 (%)
ESBL negative cases
n=83 (%) P value
XDR-KP 34 (20.9) 22 (27.5) 12 (14.5) 0.040
PDR-KP 3 (1.8) 3 (3.8) 0 0.075
Other types of KP 22 (13.5) 6 (7.5) 16 (19.3) 0.028
Treatment outcome 0.751
Treatment success 138 (84.7) 67 (83.8) 71 (85.5)
Died 25 (15.3) 13 (16.3) 12 (14.5)
doi:10.1371/journal.pone.0057091.t001
Figure 2. Comparative eBURST analysis showing the clonal assignment of the STs present in this study compared to that of the STs
in the entire K. pneumoniaMLST isolate database. Only STs in this study are given, and lines connect single locus variants. The names of the CCs
are based on the ST assigned as the founder genotype of the complex shown in blue. Subgroup founders are shown in yellow. The relative size of the
circles indicates their prevalence. New STs identified in this study are highlighted by a green halo; STs present in the database and this study are
highlighted by a pink halo.
doi:10.1371/journal.pone.0057091.g002
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prevalent clones. We detected the blaOXA-48 gene in one of the
PDR K. pneumoniae isolate (TZSKP-82).
Factors associated with prevalent K. pneumoniae clones
Factors associated with prevalent STs compared with non-
prevalent STs upon univariate and multivariate analysis are shown
in Table S5 and Table 4, respectively. Multiple logistic regression
analysis revealed that isolates from ICU (OR, 13.802), from
medical ward (OR, 5.154), from community acquired infection
(OR, 3.106), from patients without heart disease (OR, 3.446), from
patients with treatment success (OR, 6.691), susceptible to
extended spectrum cephalosporins (OR, 8.633), susceptible to
cephamycins (OR, 3.430), susceptible to fluoroquinolones (OR,
6.247), with MDR (OR, 3.111) were significantly associated with
the prevalent STs.
Discussion
The present study describes the genetic diversity of drug-
resistant K. pneumoniae isolates in a tertiary hospital in Beijing.
Twenty-four new STs were detected, demonstrating that the
MLST database is still novel and continuously growing. The
isolates originated from both CA and HA infections. It is
noteworthy that in contrast to the observations from a study from
Germany [1], the levels of resistance were equally high among
both HA and CA K. pneumoniae isolates in our study, indicating a
very large reservoir of resistance in the community around Beijing.
We further analyzed the drug resistance profiles, the correspond-
ing drug resistance-associated genes, as well as the clinical
characteristics of those isolates with the same STs. We observed
that the rates of resistance to most drugs were much higher among
ESBL positive isolates than ESBL negative isolates. But we did not
observe significant differences between ESBL blaCTX-M and
blaTEM/blaSHV groups in their distribution of STs or CCs. We
noticed that some prevalent isolates with the same STs were from
patients who were hospitalized in the same period and who shared
the same wards, especially in the first ward of the department of
respiration, NICU, and ICU, this observation suggests that those
clonal isolates were transmitted in the hospital, causing infections
among immunocompromised patients in those wards. In addition,
many patients with this ST shared the same wards such as the first
ward of the department of respiration and cardiac care unit,
suggesting there is currently an ongoing transmission of isolates of
this ST in those wards of the hospital.
Notably, among the three isolates of PDR K. pneumoniae, two
isolates belonged to ST15, which is the most prevalent ST in this
study. The clinical and molecular epidemiological data suggest
that the majority of those ST15 isolates were from patients with
severe underlying diseases such as pulmonary infection, renal
dysfunction, heart failure, and chronic obstructive pulmonary
disease, etc. A study from Spain reported that VIM-1 producing K.
pneumoniae ST15 clone has a high capacity to spread among ICU
patients with severe underlying conditions [2]. ST15 is also
widespread in other countries such as Denmark, Hungary, Korea,
Malaysia, Singapore and Taiwan [26–28]. Interestingly, one of the
PDR K. pneumoniae isolate (TZSKP-82) possesses the blaOXA-48
gene. OXA-48 carbapenemases were first isolated from K.
pneumoniae in Turkey in 2008 [10,29]. To the best of our
knowledge, this is the first documented case of OXA-48-producing
K. pneumoniae in China.
ST23 was another prevalent ST in this study. ST23 was the
primary founder of CC23, and isolates sharing this ST were found
in other countries. Previous studies showed that ST23 isolates were
closely related to liver abscess [30,31]. However, the ST23 isolates
in this study were diagnosed with different kinds of illnesses
including cerebral infarction, renal dysfunction, and liver abscess,
etc.
Another frequently identified ST is ST11, which is a single locus
variant of ST258. ST258 is a well known lineage of K. pneumoniae
which plays an important role in the global spread of
carbapenemases. ST258 was not found in our study. There are
only a few nucleotide differences between ST11 and ST258 in
their tonB alleles. ST258 was proposed to be probably arisen from
ST11 by acquisition of the tonB-79 allele, followed by acquisition of
carbapenem-resistance genes on mobile elements [32]. A recent
study was conducted to analyze carbapenem-resistant K. pneumoniae
isolates from 13 hospitals in nine cities covering five provinces in
China, and they found that ST11 was the most dominant clone
among the 95 carbapenem-resistant K. pneumoniae isolates in China
[33]. Although ST11 is not the most dominant one in our study, it
is among one of the prevalent clones and all those ST11 isolates
harbored ESBL genes. In addition, the genetic relatedness of ST11
with ST258 is of great concern.
From the maxiumum likelihood tree, a phylogenetically distinct
cluster of related STs (ST877, ST886, ST894, ST856 and ST526)
is formed. Four of them (ST877, ST886, ST894 and ST856) are
new STs in this study, and 2 of these (ST886 and ST894) differed
from recognized STs at three loci. These results suggest a recent
clone is emerging locally. Further identification of the drug
resistance profiles and epidemiological information of the 4 isolates
with new STs imply that they are relatively susceptible (with
resistance to only a few drugs and no resistance genes detected).
One of the challenges for infection control is to discern the
prevalent clones as well as their clinical relevance, especially the
treatment outcome, of those isolates, so as to provide information
for better management measures. We thus further examined the
association between certain prevalent K. pneumoniae isolates (based
on the frequency of the STs) and the demographic and clinical
features as well as mortality of the patients from whom the isolates
were obtained. We noticed that some results (For example, the
results for the association with the intensive care unit) from
univariant and multivariant analysis differ greatly. We think that
the results from the multivariant analysis should be more reliable
and those variables with significant P values in the multivariant
analysis were identified to be independently associated with
prevalent K. pneumoniae clones after excluding some less significant
variables and taking into consideration of the confounding factors
during the multivariate analysis. Data from multiple logistic
regression analysis revealed that isolates from ICU, from medical
ward, from community acquired infection, and with MDR were
significantly associated with those prevalent clones. In addition, we
noticed that those prevalent clones were more frequently
associated with patients without heart disease, who were suscep-
tible to extended spectrum cephalosporins, cephamycins and
fluoroquinolones, and who had better treatment outcome. A
recent study from Taiwan reported that the ESBL positive E. coli
ST131, which has emerged in bloodstream infections in Taiwan, is
not related to more health-care-associated risk factors, and the E.
coli bacteremia caused by this clone did not exhibited a higher
mortality rate [34]. Thus the prevalent clones are not always the
Figure 3. 50% majority-rule consensus phylogenetic tree derived from ClonalFrame for the 7 housekeeping loci in K. pneumoniae,
displaying the clonal relationship between the STs and drug resistance of the K. pneumoniae population.
doi:10.1371/journal.pone.0057091.g003
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Table 2. Distribution of sequence types in K. pneumoniae clonal complexes.
Clonal complex Sequence type Allelic profile No. of isolates No. of isolates
ESBL+ ESBL - HA CA
blaCTX-M blaTEM/blaSHV
CC23 23 2-1-1-1-9-4-12 0 0 12 7 5
11 3-3-1-1-1-1-4 5 4 3 5 4
15 1-1-1-1-1-1-1 14 11 1 10 7
17 2-1-1-1-4-4-4 3 2 1 3 1
65 2-1-2-1-10-4-13 0 0 3 3 0
340 3-3-1-1-1-1-18 0 0 2 2 0
895 3-3-1-1-1-1-42 0 0 1 1 0
815 2-1-2-1-7-1-12 0 0 1 1 0
35 2-1-2-1-10-1-19 1 1 0 1 0
268 2-1-2-1-7-1-81 0 0 1 0 1
875 2-1-2-1-10-4-19 0 0 1 0 1
25 2-1-1-1-10-4-13 0 0 2 1 1
36 2-1-2-1-7-1-7 0 0 3 3 0
218 2-3-1-1-9-4-12 1 0 1 1 1
375 43-1-2-1-10-4-13 0 0 3 3 0
412 2-1-2-1-9-1-112 0 0 7 6 1
660 2-1-2-1-4-1-25 0 0 1 0 1
685 2-1-2-1-3-4-25 1 1 0 1 0
874 4-1-1-1-7-1-22 1 0 1 1 0
887 2-1-1-1-21-4-12 0 0 1 1 0
692 2-1-2-1-1-4-42 0 0 1 0 1
879 2-1-1-1-145-1-9 0 0 1 1 0
261 2-1-1-1-4-27-12 0 0 0 1 0
462 2-1-1-6-1-4-12 4 2 0 3 2
881 2-68-1-1-10-4-13 1 1 0 1 0
CC37 37 2-9-2-1-13-1-16 3 4 1 3 2
896 2-9-2-1-13-1-38 0 0 1 1 0
884 77-9-2-1-13-1-16 1 1 0 1 0
880 2-9-2-1-1-1-16 1 1 0 1 0
CC29 29 2-3-2-2-6-4-4 0 0 1 1 0
CC101 101 2-6-1-5-4-1-6 0 0 1 1 0
888 2-6-1-5-4-1-4 1 1 0 1 0
CC86 86 9-4-2-1-1-1-27 0 0 3 3 0
CC1 1 4-4-1-1-7-4-10 3 2 0 2 1
CC12 876 6-3-1-1-12-1-110 0 0 1 1 0
CC147 147 3-4-6-1-7-4-38 5 3 3 5 3
273 3-4-6-1-7-4-4 0 0 3 2 1
CC857 857 2-35-2-35-56-24-19 0 0 1 1 0
CC584 584 4-1-2-1-1-7-4 1 1 0 1 0
CC526-928 526 38-19-53-58-73-21-130 2 2 0 2 0
CC536-856 856 16-18-21-27-39-22-105 0 0 1 1 0
CC889-7 889 3-1-1-4-3-1-19 0 0 1 0 1
Singleton 894 18-15-18-61-93-37-99 0 0 1 1 0
Singleton 893 25-1-101-1-10-1-100 0 0 1 1 0
Singleton 892 2-1-65-2-5-4-36 0 0 1 1 0
Singleton 891 3-1-2-1-9-1-184 0 0 1 1 0
Singleton 890 2-1-1-8-10-4-61 0 0 1 1 0
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Table 2. Cont.
Clonal complex Sequence type Allelic profile No. of isolates No. of isolates
ESBL+ ESBL - HA CA
blaCTX-M blaTEM/blaSHV
Singleton 886 16-1-21-27-29-17-183 0 0 1 1 0
Singleton 883 2-5-1-1-9-4-9 1 1 0 0 1
Singleton 882 2-1-1-37-1-27-19 0 0 1 1 0
Singleton 878 2-5-1-1-144-1-4 1 1 1 2 0
Singleton 877 59-24-21-78-54-22-67 0 0 1 0 1
Singleton 189 2-3-41-1-17-4-46 1 0 0 1 0
Singleton 374 2-3-58-37-10-27-9 0 0 1 1 0
Singleton 380 2-1-1-1-1-4-19 0 0 3 3 0
Singleton 562 2-5-1-1-10-1-139 9 8 1 13 1
Singleton 629 2-3-87-1-12-1-26 1 1 0 1 0
Singleton 686 4-1-1-3-3-5-54 4 3 0 4 0
Singleton 716 71-1-1-2-16-4-164 5 5 4 10 0
Singleton 873 14-1-2-1-7-4-182 0 0 1 1 0
doi:10.1371/journal.pone.0057091.t002
Figure 4. Phylogenetic tree of K. pneumoniae isolates with one representative in each ST as derived from concatenated sequences of
the 7 gene loci used in MLST. The tree was constructed using the maximum likelihood method. The phylogenetically distinct cluster is shaded.
doi:10.1371/journal.pone.0057091.g004
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most virulent ones or those associated with more severe clinical
features or outcome.
Since the prevalent clones have a great potential of transmission
among patients, the observation that those clones were signifi-
cantly associated with MDR, HA infection, as well as nosocomial
infections in the crowded ICU, together with the identification of a
large variety of drug resistance-associated genes, particularly those
ESBL genes, as well as genes associated with resistance to
fluoroquinolones and aminoglycosides [35–41], in those prevalent
clones suggest that although those isolates are associated with less
severe clinical features and outcome, they could be a dangerous
reservoir for transmission of drug resistance genes, thus warrant a
high degree of awareness and monitoring of those drug resistance
determinants in clinical isolates. In addition, these isolates from
China had different ESBL genotypes, implying multiple acquisi-
tion events and the presence of multiple circulating variants of the
clone.
In conclusion, the diversity of the genotypes and the complexity
of the resistance phenotypes and determinants found, as well as the
potential for widespread dissemination of those prevalent isolates
detected in our study suggest that certain possibly less virulent
(based on the clinical manifestations of the patients) but highly
transmissible drug-resistant clones of K. pneumoniae isolates are
currently prevalent among patients in hospital settings in Beijing,
emphasizing the continuous hospital-wide surveillance of pheno-
typic and genotypic drug resistance data, as well clinical
characteristics and treatment outcome for the prevalent K.
pneumoniae clones is necessary to understand the spread of those
successful clones, so as to make better infection control measure
against nosocomial infection caused by K. pneumoniae and
Enterobacteriaceae, which are closely related to K. pneumoniae and
interchange resistance determinants frequently with them. Further
in-depth investigation of other important population genetic
forces, such as gene flow, natural selection, etc., with more
extensive sampling, would validate the interesting observation of
an inverse relationship between prevalence and virulence in a
statistically robust fashion, as well as to provide more insights into
the spatial and temporal population dynamics of drug-resistant K.
pneumoniae isolates.
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Table 4. Multivariate logistic regression analysis for factors independently associated with prevalent K. pneumoniae clonesa.
Variablesb Univariate analysis Multivariate analysis Univariate analysis
Odds Ratio (95% CI) P value Odds Ratio (95% CI) P value
From intensive care unit 1.597 (0.814–3.135) 0.174 13.802 (3.180–59.891) ,0.001
From medical ward 1.198 (0.643–2.232) 0.570 5.154 (1.452–18.296) 0.011
Community acquired infection 1.788 (0.854–3.742) 0.123 3.106 (1.005–9.602) 0.049
With diabetes mellitus 1.244 (0.603–2.565) 0.554 2.776 (0.981–7.854) 0.054
With abnormal liver function 1.630 (0.770–3.452) 0.202 2.551 (0.924–7.042) 0.071
With cerebral infarction 1.529 (0.746–3.136) 0.246 2.528 (0.926–6.900) 0.070
Without heart disease 1.250 (0.640–2.440) 0.513 3.446 (1.298–9.150) 0.013
Treatment success 1.408 (0.582–3.406) 0.447 6.691 (1.884–23.770) 0.003
Susceptible to 3rd and 4th generation
cephalosporins
4.448 (2.268–8.722) ,0.001 8.633 (2.515–29.640) 0.001
Susceptible to cephamycins 1.072 (0.556–2.068) 0.836 3.430 (1.078–10.921) 0.037
Susceptible to fluoroquinolones 5.558 (2.823–10.943) ,0.001 6.247 (2.117–18.439) 0.001
MDR 1.291 (0.674–2.473) 0.442 3.111 (1.113–8.693) 0.030
aPrevalent clones include a total of 70 isolates with the following STs: ST15 (17), ST562 (14), ST23 (12), ST716 (10), ST11 (9), ST147 (8).
bAll variables included in the univariate analysis (shown in Table S5) were included in the logistic regression model for multivariate analysis, and they were eliminated
using a backward stepwise selection method using a P value threshold of 0.1 for the variables to remain in the model. P values,0.05 were considered to be statistically
significant.
doi:10.1371/journal.pone.0057091.t004
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